Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A.

Parry, CM; Thieu, NT; Dolecek, C; Karkey, A; Gupta, R; Turner, P; Dance, D; Maude, RR; Ha, V; Tran, CN; +25 more... Thi, PL; Be, BP; Phi, LT; Ngoc, RN; Ghose, A; Dongol, S; Campbell, JI; Thanh, DP; Thanh, TH; Moore, CE; Sona, S; Gaind, R; Deb, M; Anh, HV; Van, SN; Tinh, HT; Day, NP; Dondorp, A; Thwaites, G; Faiz, MA; Phetsouvanh, R; Newton, P; Basnyat, B; Farrar, JJ; Baker, S; (2015) Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. Antimicrobial agents and chemotherapy, 59 (5). pp. 2756-64. ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.04729-14

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1128/AAC.04729-14

Abstract

Share

Download

Filename: zac2756.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar